[Med-privacy] scrips
Peter Marshall
pwm@comcast.net
Mon, 15 May 2006 15:02:02 -0700
--Apple-Mail-3--227885211
Content-Type: multipart/alternative;
boundary=Apple-Mail-4--227885211
--Apple-Mail-4--227885211
Content-Transfer-Encoding: 7bit
Content-Type: text/plain;
charset=US-ASCII;
format=flowed
Doctors Demand Prescription Privacy
Reported by Dan Gorenstein on Wednesday, May 10, 2006.
listen:
--Apple-Mail-4--227885211
Content-Transfer-Encoding: 7bit
Content-Type: text/enriched;
charset=US-ASCII
<bold><fontfamily><param>Helvetica</param><color><param>7777,7777,7777</param>Doctors
Demand Prescription Privacy</color>
</fontfamily></bold><fontfamily><param>Helvetica</param><color><param>7777,7777,7777</param><smaller><smaller><x-tad-smaller>Reported
by
</x-tad-smaller></smaller></smaller></color><bold><color><param>3333,6666,9999</param><smaller><smaller><x-tad-smaller>Dan
Gorenstein</x-tad-smaller></smaller></smaller></color></bold><color><param>7777,7777,7777</param><smaller><smaller><x-tad-smaller>
on Wednesday, May 10,
2006.</x-tad-smaller></smaller></smaller></color><smaller><smaller><x-tad-smaller>
</x-tad-smaller></smaller><bold><color><param>E8E8,7373,0000</param><x-tad-smaller>listen:</x-tad-smaller></color></bold><smaller><x-tad-smaller> </x-tad-smaller></smaller></smaller></fontfamily>
--Apple-Mail-4--227885211--
--Apple-Mail-3--227885211
Content-Transfer-Encoding: base64
Content-Type: image/gif;
x-unix-mode=0666;
name="listen_wmp.gif"
Content-Disposition: inline;
filename=listen_wmp.gif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--Apple-Mail-3--227885211
Content-Transfer-Encoding: base64
Content-Type: image/gif;
x-unix-mode=0666;
name="listen_mp3.gif"
Content-Disposition: inline;
filename=listen_mp3.gif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--Apple-Mail-3--227885211
Content-Type: multipart/alternative;
boundary=Apple-Mail-5--227885210
--Apple-Mail-5--227885210
Content-Transfer-Encoding: 7bit
Content-Type: text/plain;
charset=US-ASCII;
format=flowed
New Hampshire lawmakers are considering a plan that would make the
state the first in the nation to prohibit the sale of the prescriptions
doctors write.
The pharmaceutical industry warns the bill poses a threat to physicians
and patients alike.
But supporters say the measure would slow rising healthcare costs and
limit the industry's influence over doctors.
New Hampshire Public Radio's Dan Gorenstein has more.
A rough transcript follows:
A few years ago psychiatrist Mark Sadowsky- who is the president of the
New Hampshire Medical Association- got a visit from a drug sales rep.
He asked Sadowsky why he was prescribing more of the competition's
medicine.
3:30 I was a bit shocked that he had such up to date information about
what I was prescribing. He was more informed than I was. I don't keep
track in a systematic way of what I prescribe.
What medicine doctors prescribe is big business.
The nation's leading prescription data collection company, IMS Health,
had revenue last year of 1.7 billion dollars.
Prescription information flows from the physician's office through
companies like IMS, and ultimately winds up in the hands of
pharmaceutical companies like Merck and Eli Lilly.
The companies then analyze the numbers and target sales.
Medical Society President Sadowsky sees the prescription information
trade as yet another of the many causes contributing to rising
healthcare costs.
1:!6 ...I think that the drug representatives that come in are
attempting to influence us to prescribe their medicines which are trade
name medicines, which are significantly more expensive than generic
medicines. At times we are being influenced to prescribe medicines that
may not be necessary either. it may be overkill.
House Bill 1346 would prohibit the sale of the prescription information.
But both the pharmaceutical industry and data collection companies
strongly oppose the measure.
Marjorie Powell of the Pharmaceutical Research and Manufactures of
America argues it would make it harder to keep doctor's informed about
the drug they prescribe.
3:31 it will be much more difficult for pharmaceutical companies to
communicate new information about product, by targeting first the
physicians who write scripts for those products. What we know about any
given drug changes over time as the drug is used and the manufacturer
acquires more and more information about the rarer side affects, and
want to get that out that information very quickly.
Powell and others say the legislation would also harm medical research.
Currently data collection companies like IMS make information available
for studies on best medical practices, public safety and drug efficacy.
For example, IMS has gathered data that shows New Hampshire is
prescribing some very strong drugs like oxycontin and codeine at twice
the rate of the national average.
That may mean nothing, but it certainly raises questions, opponents
says, like who is writing the prescriptions and why.
If HB 11346 becomes law, that information wouldn't exist.
Prime sponsor Cindy Rosenwald says has included a provision in the
legislation that allows for continued research.
She says the opposition to the measure comes down to one thing.
23:01 I think it's important to keep in mind what agencies are
supporting HB 1346 including HHS, NH Med. Society, AARP and the AG's
office. And also keep in mind which industries are opposing this
legislation...to me it is about profit.
The House is expected to vote on the plan tomorrow.
Governor John Lynch has not said whether or not he would veto the bill.
--Apple-Mail-5--227885210
Content-Transfer-Encoding: 7bit
Content-Type: text/enriched;
charset=US-ASCII
<fontfamily><param>Helvetica</param><smaller><smaller><x-tad-smaller>
New Hampshire lawmakers are considering a plan that would make the
state the first in the nation to prohibit the sale of the
prescriptions doctors write.
The pharmaceutical industry warns the bill poses a threat to
physicians and patients alike.
But supporters say the measure would slow rising healthcare costs and
limit the industry's influence over doctors.
New Hampshire Public Radio's Dan Gorenstein has more.
</x-tad-smaller></smaller><bold><x-tad-smaller>A rough transcript
follows:
</x-tad-smaller></bold><smaller><x-tad-smaller>A few years ago
psychiatrist Mark Sadowsky- who is the president of the New Hampshire
Medical Association- got a visit from a drug sales rep.
He asked Sadowsky why he was prescribing more of the competition's
medicine.
3:30 I was a bit shocked that he had such up to date information about
what I was prescribing. He was more informed than I was. I don't keep
track in a systematic way of what I prescribe.
What medicine doctors prescribe is big business.
The nation's leading prescription data collection company, IMS Health,
had revenue last year of 1.7 billion dollars.
Prescription information flows from the physician's office through
companies like IMS, and ultimately winds up in the hands of
pharmaceutical companies like Merck and Eli Lilly.
The companies then analyze the numbers and target sales.
Medical Society President Sadowsky sees the prescription information
trade as yet another of the many causes contributing to rising
healthcare costs.
1:!6 ...I think that the drug representatives that come in are
attempting to influence us to prescribe their medicines which are
trade name medicines, which are significantly more expensive than
generic medicines. At times we are being influenced to prescribe
medicines that may not be necessary either. it may be overkill.
House Bill 1346 would prohibit the sale of the prescription
information.
But both the pharmaceutical industry and data collection companies
strongly oppose the measure.
Marjorie Powell of the Pharmaceutical Research and Manufactures of
America argues it would make it harder to keep doctor's informed about
the drug they prescribe.
3:31 it will be much more difficult for pharmaceutical companies to
communicate new information about product, by targeting first the
physicians who write scripts for those products. What we know about
any given drug changes over time as the drug is used and the
manufacturer acquires more and more information about the rarer side
affects, and want to get that out that information very quickly.
Powell and others say the legislation would also harm medical research.
Currently data collection companies like IMS make information
available for studies on best medical practices, public safety and
drug efficacy.
For example, IMS has gathered data that shows New Hampshire is
prescribing some very strong drugs like oxycontin and codeine at twice
the rate of the national average.
That may mean nothing, but it certainly raises questions, opponents
says, like who is writing the prescriptions and why.
If HB 11346 becomes law, that information wouldn't exist.
Prime sponsor Cindy Rosenwald says has included a provision in the
legislation that allows for continued research.
She says the opposition to the measure comes down to one thing.
23:01 I think it's important to keep in mind what agencies are
supporting HB 1346 including HHS, NH Med. Society, AARP and the AG's
office. And also keep in mind which industries are opposing this
legislation...to me it is about profit.
The House is expected to vote on the plan tomorrow.
Governor John Lynch has not said whether or not he would veto the bill.</x-tad-smaller></smaller></smaller></fontfamily>
--Apple-Mail-5--227885210--
--Apple-Mail-3--227885211--